Skip to content

Drug interactions

Deflazacort + Sorafenib

Severity: Minor

Deflazacort and Sorafenib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Deflazacort is a corticosteroid prodrug whose active metabolite is a weak CYP3A4 inducer, so it could slightly lower sorafenib exposure. Any clinical effect is likely small and relevant mainly with prolonged use.

What this interaction means in plain words

Deflazacort and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Deflazacort belongs to Miscellaneous; Sorafenib belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 induction by deflazacort increasing sorafenib metabolism.

What to do

No dose change is normally needed; monitor tumour response during long-term co-treatment.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deflazacort and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deflazacort with Sorafenib?

MediHelp rates the interaction as minor. Deflazacort and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Deflazacort is a corticosteroid prodrug whose active metabolite is a weak CYP3A4 inducer, so it could slightly lower sorafenib exposure. Any clinical effect is likely small and relevant mainly with prolonged use.

How serious is the interaction between Deflazacort and Sorafenib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is normally needed; monitor tumour response during long-term co-treatment.

What other medicines interact with Sorafenib?

MediHelp also lists interactions of Sorafenib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sorafenib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in